CN114377090A - 治疗乙肝的特效中药胶襄 - Google Patents
治疗乙肝的特效中药胶襄 Download PDFInfo
- Publication number
- CN114377090A CN114377090A CN202011066797.7A CN202011066797A CN114377090A CN 114377090 A CN114377090 A CN 114377090A CN 202011066797 A CN202011066797 A CN 202011066797A CN 114377090 A CN114377090 A CN 114377090A
- Authority
- CN
- China
- Prior art keywords
- hepatitis
- treating hepatitis
- chinese medicine
- liver
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 33
- 239000003814 drug Substances 0.000 title claims description 23
- 239000002775 capsule Substances 0.000 title claims description 3
- 239000006187 pill Substances 0.000 claims abstract description 11
- 241000222336 Ganoderma Species 0.000 claims abstract description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 2
- 241000700721 Hepatitis B virus Species 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 11
- 230000003908 liver function Effects 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 229940126673 western medicines Drugs 0.000 description 5
- 241000522190 Desmodium Species 0.000 description 4
- 240000001659 Oldenlandia diffusa Species 0.000 description 4
- 244000038594 Phyllanthus urinaria Species 0.000 description 4
- 235000003205 Smilax rotundifolia Nutrition 0.000 description 4
- 240000009022 Smilax rotundifolia Species 0.000 description 4
- 229940126678 chinese medicines Drugs 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 244000183685 Citrus aurantium Species 0.000 description 3
- 235000007716 Citrus aurantium Nutrition 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 235000008599 Poria cocos Nutrition 0.000 description 3
- 244000197580 Poria cocos Species 0.000 description 3
- 244000179560 Prunella vulgaris Species 0.000 description 3
- 102000003929 Transaminases Human genes 0.000 description 3
- 108090000340 Transaminases Proteins 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000008113 selfheal Nutrition 0.000 description 3
- 235000014290 Artemisia anomala Nutrition 0.000 description 2
- 241000123844 Artemisia anomala Species 0.000 description 2
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000915604 Scutellaria barbata Species 0.000 description 2
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000005784 autoimmunity Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 1
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010049119 Emotional distress Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000311 effect on hepatitis Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 231100000849 liver cell damage Toxicity 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种治乙肝的中成药丸,由以下重量配比的原料制成,灵芝50克—100克，半枝莲100克‑200克、白花蛇舌草100克‑200克、茯芩100克‑200克、金刚藤80克‑160克、苦参100‑200克、枳壳60克‑120克、金钱草60克‑120克、夏枯球50克‑100克、叶下珠100克‑200,克，本发明用纯中药制成,而且本发明成本低,经济实惠,无毒副作用,治疗效果好,治愈率高,可以达到乙肝转阴的目的。
Description
技术领域:
治乙肝的中成药丸,由以下重量配比的原料制成,灵芝50克—100克，半枝莲100克-200克、白花蛇舌草100克-200克、茯芩100克-200克、金刚藤80克-160克、苦参100-200克、枳壳60克-120克、金钱草60克-120克、夏枯球50克-100克、叶下珠100克-200,克，本发明用纯中药制成,而且本发明成本低,经济实惠,无毒副作用,治疗效果好,治愈率高,可以达到乙肝转阴的目的。
背景技术:
目前,我国各地患乙肝病的患者繁多,特别是儿童,到处求医不能得到理想的治疗,同时,乙肝患者在求职的过程中,因某些职业的限制找不到自己理想的工作,同时有不少年轻人因患肝,而影响他们的婚姻和生活,同时因某些人对乙肝的认识不够,对乙肝患者产生歧视,给他们带来的精神压力和痛苦是常人无法想象的。现有治疗乙肝的中西药,虽然品种繁多,但效果都不理想,进口的西药价格昂贵,治疗时间长,大都需要治疗1年甚至几年以上,并往往停药反弹,一般的中西药只能保肝护肝,对乙肝病毒的清除起不到多大作用。本人1985年跟随老中医学习中医中药,针对乙肝治疗收集了几十种中药秘方,在多名老中医的指导下,同时查阅各种中草药资料,根据中医中药原理将处方不断更新,经过15年的试用,对乙肝的治疗整理出了一套满意的治疗方法和适用多种人群的配方,现可根据患者需求制成中成药丸以及各种常用剂型,适用各种体质的人群服用。现代医学认为,慢性乙肝糸持续感染引起的肝脏慢性炎症坏死性疾病,其发病的主要原因是机体对免疫应答而导致的肝细胞损害。中医认为慢性乙肝多由湿热邪气外袭、内蕴于脾胃肝胆,邪郁日久伤及脾气,或情志不遂,肝郁日久横逆乘脾;或苦寒清利太过伤及中阳;或脾气本虚而发病。中医把乙肝发病分为多种形式:、湿热未清;、肝郁;、脾虚;、气滞血瘀;、肝肾阴虚;、脾肾阳虚;、气血两虚。但总的慢性乙肝多由感受湿热邪气、脾虚肝郁所致。其病机为脾虚、肾虚,因此提出清热利湿,健脾疏肝,补肾、活血、退黄、降酶、抗病毒为治疗乙肝的总原则。一种治疗乙肝的中成药丸可双向调节免疫力,这是治疗乙肝的优势之一。乙肝是一种免疫性疾病,因此,在治疗乙肝时,既要积极杀灭病毒,提高机体免疫力,又要调节自身免疫力,减少肝细胞损害,这是一对矛盾,往往难以兼顾,方中的半枝莲、白花蛇舌草、金钱草、苦参、夏枯球、叶下珠清热利湿,清除乙肝病毒。广东刘寄奴、茯苓、灵芝益气健脾,提高人体免疫力,同时广东刘寄奴、金刚藤、枳壳又可以活血化瘀、行气,调整人体免疫力,防止自身免疫力亢进,起到保肝、护肝、修复肝细胞的目的。此方以调整人体生理平衡为基础,在提高人体免疫力同时,清热利湿,消除乙肝病毒,起到一个标本兼治的目的,治愈后很少反弹。同时在试治的过程中,发现此药丸对甲肝、乙肝、丙肝、脂肪肝、酒精肝及各种肝炎引起的肝纤维化、肝硬化、肝腹水、重型肝炎均有很好的治疗作用。
发明内容:
针对上述问题,本发明是一种治乙肝中成药丸能清热排毒、活血化瘀,键脾、利湿、降酶、退黄、提高免疫力,消除乙肝病毒,再达到乙肝转阴的目的。
本发明由以下重点配比原料制成:,灵芝50克—100克，半枝莲100克-200克、白花蛇舌草100克-200克、茯芩100克-200克、金刚藤80克-160克、苦参100-200克、枳壳60克-120克、金钱草60克-120克、夏枯球50克-100克、叶下珠100克-200,克。
本发明的制备方法,按上述比重称取灵芝50克—100克，半枝莲100克-200克、白花蛇舌草100克-200克、茯芩100克-200克、金刚藤80克-160克、苦参100-200克、枳壳60克-120克、金钱草60克-120克、夏枯球50克-100克、叶下珠100克-200,克，发明将上述料制成水丸(无糖),再用瓶装好备用。
用法与用量:1次10克,一日三次用开水送服。
本发明具有如下优点,可制成药丸,便于随身携带,纯中药制成,具有清热排毒,活血化瘀,健脾、利湿、降酶、退黄,提高免疫力,清除乙肝病毒,再达到乙肝转阴的日的,无毒副作用,治疗效果好,治愈率高,经济实惠。
本发明已诊治了1仟多例病患,其治疗有效率高达90%以上,疗效显著。
实施例:
]例1:熊某某:男,60岁,十年前为乙肝小三阳、乙肝病毒(HBA-DNA)基因为3×105拷贝/ml,在大小医院治疗四年之久,无好转，当时乙肝病毒(HBV-DNA)基因仍为2×105拷贝/ml,服药80天,复查,乙肝病毒(HBV-DNA)基因转阴,仍为小三阳,四年来乙肝病毒(HBV-DNA)基因仍阴性,仍有小三阳未复发。复查,发现乙肝二对半五项指标自然转阴。
例2:李某某:男,32岁患乙肝大三阳,在大小医院用药无好转,当时乙肝病毒(HBVDNA基因为2×108拷贝/ml,)肝功能长期不正常,转氨酶234U/L,总胆红素为34Umol/L,在此服药150天。复查,大三阳转小三阳,乙肝病毒(HBV-DNA)基因转1.36×10。
4拷贝/ml,未化验肝功能，继续用药30天后停药,2013年3月5日复查,肝功能正常,乙肝病毒(HBV-DNA)基因转因,仍为小三阳。
例3:刘某某:男,63岁,自己及家人患乙肝大三阳多年,肝功能长期不正常,多处就诊无好转,,当时乙肝病毒(HBV-DNA)基因为2×107拷贝/ml,肝功能不正常,其中转氨酶700U/L,总胆红素为70Umol/L,用药120天,肝功能明显好转,转为小三阳,乙肝病毒(HBV-DNA)基因为2×105拷贝/ml,继续用1个月,复查肝功能常,乙肝病毒(HBV-DNA)基因转阴停药1年复查,乙肝二对半五项指标全转阴,肝功能正常,随访四年,无复发。
Claims (2)
1.一种治乙肝的中成药丸其特征在于由以下重量配比的原料制成,灵芝50克—100克，半枝莲100克-200克、白花蛇舌草100克-200克、茯芩100克-200克、金刚藤80克-160克、苦参100-200克、枳壳60克-120克、金钱草60克-120克、夏枯球50克-100克、叶下珠100克-200,克。
2.根据权利要求1所述的一种治乙肝的中成药丸其特征在于由将上述药料制成胶襄,再用瓶装好备用，用法与用量:1次10克,一日三次用开水送服。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011066797.7A CN114377090A (zh) | 2020-10-03 | 2020-10-03 | 治疗乙肝的特效中药胶襄 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011066797.7A CN114377090A (zh) | 2020-10-03 | 2020-10-03 | 治疗乙肝的特效中药胶襄 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114377090A true CN114377090A (zh) | 2022-04-22 |
Family
ID=81193630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011066797.7A Pending CN114377090A (zh) | 2020-10-03 | 2020-10-03 | 治疗乙肝的特效中药胶襄 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114377090A (zh) |
-
2020
- 2020-10-03 CN CN202011066797.7A patent/CN114377090A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104644915A (zh) | 一种治疗酒精性肝病的药物组合物及其制备方法和用途 | |
| CN112007139B (zh) | 一种治疗寒湿郁肺型病毒性肺炎的芪桂苓中药合剂 | |
| KR20220098360A (ko) | 개나리-황기 복방제제 및 그 제조방법과 용도 | |
| CN1329047C (zh) | 治疗急性黄疸肝炎的中药组合物 | |
| CN104435977B (zh) | 一种用于治疗肝损伤的药物及其制备方法 | |
| CN1150926C (zh) | 一种治疗乙型肝炎和肝硬化的药物 | |
| CN103705578B (zh) | 具有降血脂与抑制血糖升高作用的中药制剂及其制备方法 | |
| CN114377090A (zh) | 治疗乙肝的特效中药胶襄 | |
| CN101461857B (zh) | 治疗重症肝炎的药物 | |
| CN1985902B (zh) | 一种治疗慢性肝病的中药 | |
| CN1242800C (zh) | 治疗脾胃阴虚型萎缩性胃炎的中药制剂 | |
| CN111407808A (zh) | 一种抗疫中药组合物及其制备方法与制药应用 | |
| CN104998158A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
| CN111588757A (zh) | 一种治疗慢性阻塞性肺疾病稳定期的中药组合物及制备方法 | |
| CN102861136A (zh) | 一种治疗肺炎的药物及其制备方法 | |
| CN116850224B (zh) | 一种用于防治疫病的中药组合物及其制备方法 | |
| CN107320682A (zh) | 一种治疗乙肝的药物 | |
| CN103585323B (zh) | 治疗乙肝病毒大三阳的中药制剂 | |
| CN109999155B (zh) | 治疗阿尔茨海默病的中药组合物及其制备方法 | |
| CN1311863C (zh) | 一种肝胆同治的中药及其制备方法 | |
| CN106389768A (zh) | 一种治疗鼻科疾病的药物组合及其制备方法 | |
| CN100409884C (zh) | 一种治疗感冒的中药 | |
| CN100515452C (zh) | 五味消毒饮现代中药口服制剂 | |
| CN100475262C (zh) | 一种预防治疗非典型肺炎与病毒性肝炎合并症的疏肝理气保肝药 | |
| CN101537041B (zh) | 一种治疗甲型肝炎和乙型肝炎的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220422 |